X

Health Care

TRxADE Health changes its name to Scienture Holdings

Trxade Health, Inc. (NASDAQ: MEDS), a leading health services IT company, and its wholly owned subsidiary Scienture, LLC revealed that…

IPO News: Everything you need to know about BioAge Labs’ IPO

BioAge Labs, Inc. is the latest among the healthcare companies pursuing stock-market listing this year. In a registration statement filed…

Guardian Pharmacy seeks to raise up to $108 mil in US IPO

Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to…

Everything you need to know about Zenas BioPharma’s IPO

Zenas BioPharma, Inc. is among the latest healthcare companies to jump on the IPO bandwagon, filing its prospectus even as…

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new therapeutic candidates efficiently from the laboratory…

Medtronic bets on innovation and new technology to drive long-term growth

Over the years, Medtronic plc (NYSE: MDT) has constantly strengthened its position in the medical device industry by innovating the…

Medtronic (MDT) reports higher revenue and profit for Q1 2025

Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues and adjusted profit for the first quarter of…

Trxade Health (MEDS) Q2 2024 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform with a mission to revolutionize the healthcare industry…

Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2024 results

Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Wednesday reported an increase in revenues and adjusted profit for the…

MEDS Earnings: A snapshot of Trxade’s Q2 2024 results

Health services IT company Trxade Health, Inc. (NASDAQ: MEDS) announced financial results for the second quarter of 2024, reporting a…

Earnings Summary: Gilead Sciences reports higher Q2 revenue and profit

Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, has reported an increase in revenues and adjusted earnings for…

LLY Earnings: Highlights of Eli Lilly’s Q2 2024 financial report

Eli Lilly and Company (NYSE: LLY) on Thursday reported a double-digit increase in revenues and profit for the second quarter…

Earnings Summary: A snapshot of Bio-Techne’s (TECH) Q4 2024 results

Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Wednesday announced financial results for the fourth quarter of 2024, reporting a decline…

CVS Earnings: CVS Health Q2 adj. profit drops but beats estimates

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced second-quarter 2024 results, reporting a decrease in adjusted earnings despite…

CVS Health to report Q2 2024 results on Wednesday. Here’s what to expect

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) had a modest start to fiscal 2024, with sales and profit coming under…

Earnings Summary: Moderna reports Q2 2024 financial results

Biotechnology company Moderna, Inc. (NASDAQ: MRNA) Thursday reported a sharp decline in revenues for the second quarter of 2024. Second-quarter…

Biogen (BIIB) Q2 2024 Earnings: Key financials and quarterly highlights

Biogen Inc. (NASDAQ: BIIB) reported its second quarter 2024 earnings results today. Total revenue of $2.5 billion was flat at…

Earnings Summary: Highlights of Humana’s Q2 2024 report

Humana Inc. (NYSE: HUM), a leading health and well-being company, reported a decrease in adjusted earnings for the second quarter…

Merck (MRK) swings to profit in Q2 on higher revenues; earnings beat

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported net profit for the second quarter of 2024, on an adjusted…

Pfizer (PFE) Q2 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today. Revenues increased 2% year-over-year to $13.3 billion. Revenues…

Earnings Summary: A snapshot of DexCom’s Q2 2024 financial results

Healthcare company DexCom, Inc. (NASDAQ: DXCM) has reported an increase in revenue and adjusted earnings for the second quarter of…